Lippo Karawaci Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Lippo Karawaci Tbk. trades at Rp61 (market cap 4.32T, 78.75M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Lippo Karawaci Tbk. is far larger — about 26× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Lippo Karawaci Tbk. is more actively traded (78.75M versus 324K). Which is the better fit depends on your goals.
| LPKR | OBAT | |
|---|---|---|
Market Cap | 4.32T | 166.01B |
Volume | 78.75M | 324K |
Lot | 787.51K | 3.24K |
Turnover | 4.81B | 77.68M |
Average Price | 61.05 | 239.75 |
Value | 4.81B | 77.68M |
Indicative Equilibrium Price | 61 | 240 |
Indicative Equilibrium Volume | 28.62K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Read more on LPKR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →